central nervous system leukemia
central nervous system leukemia
Explore linked clinical trials. Standard reference: MONDO:00016062 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, acute biphenotypic leukemia, central nervous system leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mixed phenotype acute leukemia, neoplasm, testicular leukemia, viral infectious disease | Recruiting | Phase 3 | 2026-08-25 | NCT03959085 | |
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | Chromosome 7, monosomy, Chromosome Aberrations, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infections, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, RNA Virus Infections, acute leukemia, acute myeloid leukemia, anemia, beta thalassemia, bone marrow disorder, central nervous system leukemia, familial hemolytic anemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemolytic anemia, hereditary disease, hereditary neoplastic syndrome, immune system disorder, immunoproliferative disorder, influenza, inherited hemoglobinopathy, inherited neurodegenerative disorder, juvenile myelomonocytic leukemia, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, respiratory system disorder, respiratory tract infectious disorder, thalassemia, viral infectious disease | Recruiting | Phase 2 | 2026-04-06 | NCT05735717 |